GPN Vaccines, Inc. closes a fully subscribed $10 million private placement to support the advancement of Gamma-PN, its innovative pneumococcal vaccine.
Amount Raised
$10 Million
Round Type
Post-IPO Equity
YarralumlaBiotechnologyDescription
GPN Vaccines, Inc. has announced the successful closing of a $10 million private placement financing with new and existing investors. The funds raised will facilitate Phase 2 clinical development of Gamma-PN, including manufacturing and testing capabilities. Plans include the submission of an Investigational New Drug (IND) application to the FDA
Who to call at GPN Vaccines, and when
A new round usually means GPN Vaccines is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day GPN Vaccines raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at GPN Vaccines, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at GPN Vaccines. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment GPN Vaccines raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
GPN Vaccines raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.